85 related articles for article (PubMed ID: 33999708)
1. Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India.
Gupta N; Chauhan AS; Prinja S; Pandey AK
JCO Glob Oncol; 2021 May; 7():716-725. PubMed ID: 33999708
[TBL] [Abstract][Full Text] [Related]
2. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
[TBL] [Abstract][Full Text] [Related]
3. Gynecologic cancer care in the first year of the COVID-19 pandemic.
Chapman GC; Smrz SA; Gordon JC; Lynam SK; Strohl AE; Ferguson LA; Armstrong AJ; Zanotti KM
Gynecol Oncol; 2023 Nov; 178():138-144. PubMed ID: 37862793
[TBL] [Abstract][Full Text] [Related]
4. Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country.
da Silva IF; da Silva IF; Saraceni V; Koifman RJ
Cancer Epidemiol; 2023 Oct; 86():102450. PubMed ID: 37678095
[TBL] [Abstract][Full Text] [Related]
5. The beginning of the end for cervical cancer in India.
Jayraj AS; Singhal S
Int J Gynecol Cancer; 2024 Mar; ():. PubMed ID: 38453178
[No Abstract] [Full Text] [Related]
6. Clinical spectrum and outcome of patients visiting coronavirus screening centre in North India and clinical predictors for COVID-19.
Singla N; Gowda R; Mohindra R; Suri V; Dhibar DP; Sharma N
J Family Med Prim Care; 2021 Jan; 10(1):454-461. PubMed ID: 34017770
[TBL] [Abstract][Full Text] [Related]
7. Changes of clinical characteristics of asymptomatic patients with positive SARS-Cov-2 nucleic acid test during treatment cycle and related risk factors.
Li S; Li J; Cao D; Hao X; Wei Y; Hasi C; Zhang X; Kong X
Am J Transl Res; 2021; 13(4):3650-3657. PubMed ID: 34017547
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer patients with COVID-19 in Spain: GRAVID study.
Provencio M; Mazarico Gallego JM; Calles A; Antoñanzas M; Pangua C; Mielgo Rubio X; Nadal E; Castro RL; López-Martín A; Del Barco E; Dómine M; Franco F; Diz P; Sandoval C; Girona ES; Sullivan I; Sala MÁ; Ledo GG; Cucurull M; Mosquera J; Martínez M; Chara LE; Arriola E; Herrera BE; Jarabo JR; Álvarez RÁ; Baena J; Cao MG
Lung Cancer; 2021 Jul; 157():109-115. PubMed ID: 34016490
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.
Wentzensen N; Clarke MA; Perkins RB
Prev Med; 2021 Oct; 151():106596. PubMed ID: 34217415
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and Cancer: A Comparison of the Two Important Pandemic Waves in an Indian Cancer Patients' Cohort.
Batra U; Nathany S; Sharma M; Saha S; Kumar D; Jose JT; Singh H
South Asian J Cancer; 2024 Jan; 13(1):57-62. PubMed ID: 38721103
[TBL] [Abstract][Full Text] [Related]
11. Surviving the Storm: The Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries.
Vahabi M; Shahil-Feroz A; Lofters A; Wong JP; Prakash V; Pimple S; Anand K; Mishra G
Healthcare (Basel); 2023 Dec; 11(23):. PubMed ID: 38063647
[TBL] [Abstract][Full Text] [Related]
12. The effect of COVID-19 on the cervical screening programme within a Northern Irish Health and Social care trust.
McMullan JC; Rainey L; Morgan D; Johnston L
Ulster Med J; 2023 May; 92(2):84-88. PubMed ID: 37649920
[TBL] [Abstract][Full Text] [Related]
13. The recovery strategies to support cervical cancer elimination in lower-and middle-income countries (LMICs) following COVID-19 disruptions.
Lee J; Ismail-Pratt I; Machalek DA; Kumarasamy S; Garland SM
Prev Med Rep; 2023 Oct; 35():102291. PubMed ID: 37455756
[TBL] [Abstract][Full Text] [Related]
14. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
Elife; 2023 Jun; 12():. PubMed ID: 37377399
[TBL] [Abstract][Full Text] [Related]
15. Estimating Excess Mortality Due to Prostate, Breast, and Uterus Cancer during the COVID-19 Pandemic in Peru: A Time Series Analysis.
Ramírez-Soto MC; Salazar-Peña M; Vargas-Herrera J
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36982065
[TBL] [Abstract][Full Text] [Related]
16. Physical and mental health outcomes of COVID-19 induced delay in oncological care: A systematic review.
van Vliet ED; Eijkelboom AH; van Giessen A; Siesling S; de Wit GA
Front Oncol; 2023; 13():998940. PubMed ID: 36776332
[TBL] [Abstract][Full Text] [Related]
17. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract][Full Text] [Related]
18. How can health technology assessment support our response to public health emergencies?
Ananthakrishnan A; Luz ACG; Kc S; Ong L; Oh C; Isaranuwatchai W; Dabak SV; Teerawattananon Y; Turner HC
Health Res Policy Syst; 2022 Nov; 20(1):124. PubMed ID: 36333759
[TBL] [Abstract][Full Text] [Related]
19. Cancer surgery during COVID increased the patient mortality and the transmission risk to healthcare workers: results from a retrospective cohort study (NCT05240378).
Soni K; Neville JF; Purwar R; Kumar T; Yadav G; Verma N; Pandey M
World J Surg Oncol; 2022 Sep; 20(1):302. PubMed ID: 36127678
[TBL] [Abstract][Full Text] [Related]
20. Management of Gynecologic Cancer During COVID-19 Pandemic: South Asian Perspective.
Singh N; Mishra N; Jayraj AS; Ghatage P
Cancer Control; 2022; 29():10732748221119349. PubMed ID: 36036360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
